Investing Theriva Biologics stock soars after EMA backs Phase 3 trial design Dylan D. DavisDecember 29, 2025 Theriva Biologics stock soars after EMA backs Phase 3 trial design Source link
Asia fund managers turn upbeat on growth but temper return expectations: BofA Asia fund managers turn upbeat on growth but temper return expectations: BofA Source link
Buy this chipmaker over Nvidia as AI competition ramps up, strategist says Investors can look to Taiwan Semiconductor Manufacturing for a steady way to play the artificial intelligence rally, according to F.L.Putnam…
JPMorgan’s report shows strong equity ETF inflows as CTAs maintain positions JPMorgan’s report shows strong equity ETF inflows as CTAs maintain positions Source link
